Related Experiment Video
Updated: Jun 1, 2026

Collecting Hair Samples for Hair Cortisol Analysis in African Americans
Published on: June 10, 2018
Racial/ethnic differences in hormonally-active hair product use: a plausible risk factor for health disparities
Tamarra James-Todd1, Ruby Senie, Mary Beth Terry
1Division of Women's Health, Department of Medicine, Connors Center for Women's Health and Gender Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02120, USA. tjames-todd@bics.bwh.harvard.edu
Abstract:
Estrogen and endocrine-disrupting chemicals (EDCs) that are associated with several health outcomes have been found in hair products. We evaluated the proportion, frequency, duration, and content of hair products in a racially/ethnically diverse population. We recruited n = 301 African-American, African-Caribbean, Hispanic, and white women from the New York metropolitan area. We collected data on hair oil, lotion, leave-in conditioner, root stimulator, perm, and other product use. Estrogen and EDC information was collected from commonly used hair products' labels (used by >3% of population). African-American and African-Caribbean women were more likely to use all types of hair products compared to white women (P < 0.0001). Among hair product users, frequency varied significantly by race/ethnicity, but not duration. More African-Americans (49.4%) and African-Caribbeans (26.4%) used products containing placenta or EDCs compared to whites (7.7%). African-American and African-Caribbean women were more likely to be exposed to hormonally-active chemicals in hair products.
Related Concept Videos
Drug Toxicity: Risk factors
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Stereotypes, Prejudice, and Discrimination
Principles of Pharmacogenetics: Types of Genetic Variants
Accessory Structures of the Skin: Hair Growth and Types
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...

